Formoterol is more potent and more effective than salmeterol in the inhibition of oxidative burst in human eosinophils Source: Eur Respir J 2001; 18: Suppl. 33, 49s Year: 2001
Formoterol but not salmeterol enhances cytokine release Source: Eur Respir J 2002; 20: Suppl. 38, 619s Year: 2002
Budesonide prevents cytokine-induced decrease of the relaxant response to formoterol but not to salmeterol in mouse trachea Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009
Combined treatment with fluticasone plus salmeterol protects against allergen-induced asthmatic responses better than each drug alone Source: Eur Respir J 2001; 18: Suppl. 33, 349s Year: 2001
Combination of budesonide and formoterol is more effective in inhibiting GM-CSF production by bronchial epithelial cells than either drug alone Source: Eur Respir J 2003; 22: Suppl. 45, 457s Year: 2003
Additive blockade of β2-integrin adhesion of eosinophils by salmeterol and fluticasone propionate Source: Eur Respir J 2004; 24: 333 Year: 2004
Long-term effect of salmeterol and fluticasone propionate on β2 -integrin mediated adhesion of neutrophils: role of annexin-1 in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 103s Year: 2006
Differences in efficacy between formoterol and salmeterol in relaxation of the mouse trachea are accentuated by inflammatory cytokines Source: Eur Respir J 2005; 26: Suppl. 49, 370s Year: 2005
Synergistic inhibition of oxidative burst in human eosinophils by combination treatment with formoterol and budesonide Source: Eur Respir J 2001; 18: Suppl. 33, 48s Year: 2001
Fluticasone does not add to the salmeterol effect on pig-dust induced inflammation in the lower airways Source: Eur Respir J 2006; 28: Suppl. 50, 433s Year: 2006
Combined treatment with fluticasone plus salmeterol protects against allergen induced asthmatic responses and subsequent increase in sputum eosinophils Source: Eur Respir J 2002; 20: Suppl. 38, 189s Year: 2002
Synergistic effect of fluticasone propionate and salmeterol on T-lymphocytes in inhibiting proliferation in vitro Source: Annual Congress 2009 - Inflammatory cells and cytokines Year: 2009
Inhibitory effects of formoterol, budesonide and tiotropium bromide on human neutrophils in vitro Source: Eur Respir J 2003; 22: Suppl. 45, 286s Year: 2003
Formoterol turbuhaler is as effective as salbutamol diskus in relieving adenosine- induced bronchoconstriction Source: Eur Respir J 2004; 24: Suppl. 48, 166s Year: 2004
Acute protection against exercise-induced bronchoconstriction by formoterol, salmeterol and terbutaline Source: Eur Respir J 2002; 19: 865-871 Year: 2002
Anti-inflammatory effect of beclomethasone dipropionate and formoterol on TNF-α-induced human endothelial cell activation Source: Annual Congress 2011 - Lung cell biology Year: 2011
Effect of montelukast or salmeterol added to inhaled fluticasone on response to albuterol in children with exercise-induced bronchoconstriction Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
Attenuation of exercise-induced bronchoconstriction with montelukast or salmeterol added to inhaled fluticasone in children Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
The effects of treatment with fluticasone propionate alone and combination with salmeterol on asthma control and airway inflammation Source: Eur Respir J 2003; 22: Suppl. 45, 287s Year: 2003
Formoterol and salmeterol enhance cytokine release in primary bronchial epithelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 101s Year: 2004